Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy.

The firm’s CEO cited a “very competitive” recruiting market in 2024, but forecasts a better 2025 as longer-term efforts pay ...

JMP Securities raised the firm’s price target on Stifel Financial (SF) to $135 from $125 and keeps an Outperform rating on the shares. Stifel ...

In a report released today, Michael Brown from Wells Fargo maintained a Buy rating on Stifel Financial (SF – Research Report), with a price ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $125.6, a high estimate of $135.00, and a low estimate of $115.00. This upward trend is evident, ...

CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced Getinge off the U.S. market in 2015.

Stifel Financial Corp (NYSE:SF) shares soared to an all-time high this week, reaching a peak of $119.23 USD. The $12 billion ...

Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $89.57 which represents a decrease of $-0.29 or -0.32% from the prior close of $89.86. The stock opened at $90.11 and touched a low of ...

Chrysalis stock has jumped after its private equity holdings, Klarna and Starling Bank, saw significant upgrades to their ...

The Financial Conduct Authority (FCA) has been warned that some investors would no longer funnel their capital into the investment companies sector if the regulator proceeds with some of its proposals ...

The natural beauty of West Virginia will be celebrated both musically and visually in the Wheeling Symphony Orchestra’s upcoming performance, “Nature. Beauty.” Set for 2 p.m., Feb. 8, at the Capitol ...

IBM (NYSE: IBM) stock has surged significantly in after-hours trading by 10% and 9% in pre-market trading. This is due to IBM reporting solid Q4 2024 results and bullish guidance for 2025. Here’s ...